Pub. Date : 2021 Apr
PMID : 33296093
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Post-treatment TMZ-associated hypermutation is a mechanism for TMZ resistance in recurrent isocitrate dehydrogenase (IDH) wildtype glioblastoma and may be seen in association with tumour progression in lower-grade IDH-mutant diffuse astrocytic gliomas. | Temozolomide | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
| 2 | Post-treatment TMZ-associated hypermutation is a mechanism for TMZ resistance in recurrent isocitrate dehydrogenase (IDH) wildtype glioblastoma and may be seen in association with tumour progression in lower-grade IDH-mutant diffuse astrocytic gliomas. | Temozolomide | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
| 3 | Post-treatment TMZ-associated hypermutation is a mechanism for TMZ resistance in recurrent isocitrate dehydrogenase (IDH) wildtype glioblastoma and may be seen in association with tumour progression in lower-grade IDH-mutant diffuse astrocytic gliomas. | Temozolomide | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
| 4 | Post-treatment TMZ-associated hypermutation is a mechanism for TMZ resistance in recurrent isocitrate dehydrogenase (IDH) wildtype glioblastoma and may be seen in association with tumour progression in lower-grade IDH-mutant diffuse astrocytic gliomas. | Temozolomide | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |
| 5 | Post-treatment TMZ-associated hypermutation is a mechanism for TMZ resistance in recurrent isocitrate dehydrogenase (IDH) wildtype glioblastoma and may be seen in association with tumour progression in lower-grade IDH-mutant diffuse astrocytic gliomas. | Temozolomide | isocitrate dehydrogenase (NADP(+)) 1 | Homo sapiens |